These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39295527)

  • 21. Clinical Practice Guideline Reduces Evaluation and Treatment for Febrile Infants 0 to 56 Days of Age.
    Mercurio L; Hill R; Duffy S; Zonfrillo MR
    Clin Pediatr (Phila); 2020 Sep; 59(9-10):893-901. PubMed ID: 32468838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement.
    Burstein B; Alathari N; Papenburg J
    Pediatrics; 2022 Jun; 149(6):. PubMed ID: 35578916
    [No Abstract]   [Full Text] [Related]  

  • 23. Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
    Stalenhoef JE; van Nieuwkoop C; Wilson DC; van der Starre WE; van der Reijden TJK; Delfos NM; Leyten EMS; Koster T; Ablij HC; van 't Wout JJW; van Dissel JT
    BMC Infect Dis; 2019 Feb; 19(1):161. PubMed ID: 30764769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multicenter evaluation of adherence to the Dutch guideline for children aged 0-16 years with fever without a source-febrile illness in children (FINCH) study.
    Keuning MW; Klarenbeek NN; Bout HJ; Broer A; Draaijer M; Hol J; Hollander N; Merelle M; Nassar-Sheikh Rashid A; Nusman C; Oostenbroek E; Ridderikhof ML; Roelofs M; van Rossem E; van der Schoor SRD; Schouten SM; Taselaar P; Vasse K; van Wermeskerken AM; van der Zande JMJ; Zuurbier R; Bijlsma MW; Pajkrt D; Plötz FB
    Eur J Pediatr; 2024 Jul; 183(7):2921-2933. PubMed ID: 38619569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing Invasive Care for Low-risk Febrile Infants Through Implementation of a Clinical Pathway.
    Kasmire KE; Hoppa EC; Patel PP; Boch KN; Sacco T; Waynik IY
    Pediatrics; 2019 Mar; 143(3):. PubMed ID: 30728272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum procalcitonin concentration in the evaluation of febrile infants 2 to 60 days of age.
    Woelker JU; Sinha M; Christopher NC; Powell KR
    Pediatr Emerg Care; 2012 May; 28(5):410-5. PubMed ID: 22531197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Febrile Infant: Updates in Evaluation and Management.
    Perlman J
    Pediatr Ann; 2024 Sep; 53(9):e314-e319. PubMed ID: 39240176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.
    Williams EJ; Mair L; de Silva TI; Green DJ; House P; Cawthron K; Gillies C; Wigfull J; Parsons H; Partridge DG
    J Hosp Infect; 2021 Apr; 110():103-107. PubMed ID: 33484783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to guidelines for managing the well-appearing febrile infant: assessment using a case-based, interactive survey.
    Meehan WP; Fleegler E; Bachur RG
    Pediatr Emerg Care; 2010 Dec; 26(12):875-80. PubMed ID: 21088637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of emergency department prediction tools in evaluating febrile young infants at risk for serious infections.
    Yao SHW; Ong GY; Maconochie IK; Lee KP; Chong SL
    Emerg Med J; 2019 Dec; 36(12):729-735. PubMed ID: 31653694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Clinical Outcomes and Hospital Guidelines for Cerebrospinal Fluid Testing in Febrile Infants Aged 29-56 Days.
    Chua KP; Neuman MI; McWilliams JM; Aronson PL;
    J Pediatr; 2015 Dec; 167(6):1340-6.e9. PubMed ID: 26477870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of the Febrile Young Infant: Update for the 21st Century.
    Woll C; Neuman MI; Aronson PL
    Pediatr Emerg Care; 2017 Nov; 33(11):748-753. PubMed ID: 29095773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic test accuracy of procalcitonin and C-reactive protein for predicting invasive and serious bacterial infections in young febrile infants: a systematic review and meta-analysis.
    Norman-Bruce H; Umana E; Mills C; Mitchell H; McFetridge L; McCleary D; Waterfield T
    Lancet Child Adolesc Health; 2024 May; 8(5):358-368. PubMed ID: 38499017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study.
    Waterfield T; Maney JA; Hanna M; Fairley D; Shields MD
    BMC Pediatr; 2018 Dec; 18(1):387. PubMed ID: 30541505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the Diagnosis and Management of Febrile Infants: Challenging Tradition.
    Pantell RH; Roberts KB; Greenhow TL; Pantell MS
    Adv Pediatr; 2018 Aug; 65(1):173-208. PubMed ID: 30053923
    [No Abstract]   [Full Text] [Related]  

  • 36. Procalcitonin as a Predictive Marker for Bacteremia in Children With a Central Line and Fever.
    Damman J; Arias P; Kerner J; Zhang KY; Dehghan M; Krishnan G; Nespor C; Bensen R; Park KT
    Hosp Pediatr; 2019 Jun; 9(6):434-439. PubMed ID: 31097470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of febrile infants aged 1 month and less than 3 months in a French university hospital: Clinical practice evaluation.
    Belleau C; Grimaud C; Pillet P; Bailhache M
    Arch Pediatr; 2019 Sep; 26(6):313-319. PubMed ID: 31358405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs and infant outcomes after implementation of a care process model for febrile infants.
    Byington CL; Reynolds CC; Korgenski K; Sheng X; Valentine KJ; Nelson RE; Daly JA; Osguthorpe RJ; James B; Savitz L; Pavia AT; Clark EB
    Pediatrics; 2012 Jul; 130(1):e16-24. PubMed ID: 22732178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study.
    Park JS; Byun YH; Lee JY; Lee JS; Ryu JM; Choi SJ
    BMC Pediatr; 2021 Mar; 21(1):109. PubMed ID: 33663442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the young febrile child: a commentary on recent practice guidelines.
    Kramer MS; Shapiro ED
    Pediatrics; 1997 Jul; 100(1):128-34. PubMed ID: 9200370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.